Lexicon Pharmaceuticals
LXRX
#7400
Rank
A$0.65 B
Marketcap
A$1.80
Share price
-0.82%
Change (1 day)
35.51%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): A-$0.30

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$0.28. In 2024 the company made an earnings per share (EPS) of A-$0.95 an increase over its 2023 EPS that were of A-$1.19.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.30-68.28%
2024A-$0.95-20%
2023A-$1.1931.15%
2022A-$0.91-0%
2021A-$0.9110.91%
2020A-$0.82-145.08%
2019A$1.82-206.09%
2018A-$1.71-5.74%
2017A-$1.82-10.95%
2016A-$2.042640%
2015A-$0.07442-96.34%
2014A-$2.03-2.53%
2013A-$2.08-9.09%
2012A-$2.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
A-$114.18 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$64.66-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A-$8.84 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$4.05-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$25.81-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.74 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$6.65-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$3.56-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A-$1.12 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA